Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection

Journal of Steroid Biochemistry and Molecular Biology

Volumn 146, Issue , 2015, Pages 48-61

  Guennoun, R ^a   Labombarda, F ^b   Gonzalez Deniselle, M C ^b   Liere, P ^a   De Nicola, A F ^b   Schumacher, M ^a  

^a Universite Paris Sud   (France)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

GABAA receptors; Membrane progesterone receptor component 1 (PGRMC1); Membrane progesterone receptors (mPR); Neurosteroids; Progesterone receptors (PR); Progestins

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5ALPHA PREGNANE 3,20 DIONE; CELL NUCLEUS RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; ELTANOLONE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; PGRMC1 PROTEIN, HUMAN;

BRAIN; BRAIN ISCHEMIA; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; ENZYME LOCALIZATION; HORMONE ACTION; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; INTRACELLULAR SIGNALING; NERVE DEGENERATION; NERVOUS SYSTEM INJURY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; REVIEW; SPINAL CORD; SPINAL CORD INJURY; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; DEGENERATIVE DISEASE; FEMALE; MALE; METABOLISM;

ANIMALS; BRAIN; BRAIN INJURIES; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PREGNANOLONE; PROGESTERONE; RECEPTORS, GABA-A; RECEPTORS, PROGESTERONE; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84916888665     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.09.001     Document Type: Review

References (204)

1. C.K. Kellogg, C.A. Frye, Endogenous levels of 5 alpha-reduced progestins and androgens in fetal vs. adult rat brains, Brain Res. Dev. Brain Res. 115 (1999) 17-24.
2. P.J. Brunton, J.A. Russell, Allopregnanolone and suppressed hypothalamo-pituitary-adrenal axis stress responses in late pregnancy in the rat, Stress 14 (2011) 6-12.
3. P.J. Brunton, J.A. Russell, The expectant brain: adapting for motherhood, Nat. Rev. Neurosci. 9 (2008) 11-25.
4. J. Maguire, I. Ferando, C. Simonsen, I. Mody, Excitability changes related to GABAA receptor plasticity during pregnancy, J. Neurosci. 29 (2009) 9592-9601.
5. J. Maguire, I. Mody, Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress, J Neurosci 27 (2007) 2155-2162.
6. S.M. Paul, R.H. Purdy, Neuroactive steroids, Faseb J. 6 (1992) 2311-2322.
7. R.H. Purdy, A.L. Morrow, P.H. Moore, S.M. Paul Jr., Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain, Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4553-4557.
8. R.C. Melcangi, S. Giatti, D. Calabrese, M. Pesaresi, G. Cermenati, N. Mitro, B. Viviani, L.M. Garcia-Segura, D. Caruso, Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions, Prog. Neurobiol. 113 (2014) 56-69.
9. R.D. Brinton, Neurosteroids as regenerative agents in the brain: therapeutic implications, Nat. Rev.. Endocrinol. 9 (2013) 241-250.
10. M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, E.E. Baulieu, Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system, Endocr. Rev. 28 (2007) 387-439.
11. M. Schumacher, C. Mattern, A. Ghoumari, J.P. Oudinet, P. Liere, F. Labombarda, R. Sitruk-Ware, A.F. De Nicola, R. Guennoun, Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors, Prog. Neurobiol. 113 (2014) 6-39.
12. D.G. Stein, Progesterone exerts neuroprotective effects after brain injury, Brain Res. Rev. 57 (2008) 386-397.
13. A.F. De Nicola, F. Labombarda, M.C. Deniselle, S.L. Gonzalez, L. Garay, M. Meyer, G. Gargiulo, R. Guennoun, M. Schumacher, Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration, Front Neuroendocrinol. 30 (2009) 173-187.
14. M. Djebaili, Q. Guo, E.H. Pettus, S.W. Hoffman, D.G. Stein, The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats, J. Neurotrauma 22 (2005) 106-118.
15. M. Djebaili, S.W. Hoffman, D.G. Stein, Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat prefrontal cortex, Neuroscience 123 (2004) 349-359.
16. I. Sayeed, Q. Guo, S.W. Hoffman, D.G. Stein, Allopregnanolone a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion, Ann. Emerg. Med. 47 (2006) 381-389.
17. I. Sayeed, D.G. Stein, Progesterone as a neuroprotective factor in traumatic and ischemic brain injury, Prog. Brain Res. 175 (2009) 219-237.
18. L.D. Griffin, W. Gong, L. Verot, S.H. Mellon, Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone, Nat. Med. 10 (2004) 704-711.
19. J. Wang, C. Jiang, C. Liu, X. Li, N. Chen, Y. Hao, Neuroprotective effects of progesterone following stroke in aged rats, Behav. Brain Res. 209 (2010) 119-122.
20. R.C. Melcangi, A.G. Mensah-Nyagan, Neuroprotective effects of neuroactive steroids in the spinal cord and peripheral nerves, J. Mol. Neurosci. 28 (2006) 1-2.
21. C.L. Gibson, B. Coomber, J. Rathbone, Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke? Neuroscientist 15 (2009) 324-332.
22. A. Liu, I. Margaill, S. Zhang, F. Labombarda, B. Coqueran, B. Delespierre, P. Liere, C. Marchand-Leroux, B.W. O'Malley, J.P. Lydon, A.F. De Nicola, R. Sitruk- Ware, C. Mattern, M. Plotkine, M. Schumacher, R. Guennoun, Progesterone receptors: a key for neuroprotection in experimental stroke, Endocrinology 153 (2012) 3747-3757.
23. F. Labombarda, A.M. Ghoumari, P. Liere, A.F. De Nicola, M. Schumacher, R. Guennoun, Neuroprotection by steroids after neurotrauma in organotypic spinal cord cultures: a key role for progesterone receptors and steroidal modulators of GABA(A) receptors, Neuropharmacology 71 (2013) 46-55.
24. I. Ciriza, I. Azcoitia, L.M. Garcia-Segura, Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo, J. Neuroendocrinol. 16 (2004) 58-63.
25. I. Ciriza, P. Carrero, C.A. Frye, L.M. Garcia-Segura, Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective, J. Neurobiol. 66 (2006) 916-928.
26. Y. Ishihara, T. Kawami, A. Ishida, T. Yamazaki, Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices, J. Steroid Biochem. Mol. Biol. 135 (2013) 1-6.
27. A. Furukawa, A. Miyatake, T. Ohnishi, Y. Ichikawa, Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450SCC (CYP XIA1), and 3beta-hydroxysteroid dehydrogenase in the rat brain, J. Neurochem. 71 (1998) 2231-2238.
28. J.L. Do Rego, J.Y. Seong, D. Burel, J. Leprince, V. Luu-The, K. Tsutsui, M.C. Tonon, G. Pelletier, H. Vaudry, Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides, Front Neuroendocrinol. 30 (2009) 259-301.
29. R. Guennoun, R.J. Fiddes, M. Gouezou, M. Lombes, E.E. Baulieu, A key enzyme in the biosynthesis of neurosteroids, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta-HSD), is expressed in rat brain, Brain Res. Mol. Brain Res. 30 (1995) 287-300.
30. C. Ibanez, R. Guennoun, P. Liere, B. Eychenne, A. Pianos, M. El-Etr, E.E. Baulieu, M. Schumacher, Developmental expression of genes involved in neurosteroidogenesis: 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase in the rat brain, Endocrinology 144 (2003) 2902-2911.
31. S.H. Mellon, L.D. Griffin, Neurosteroids: biochemistry and clinical significance, Trends Endocrinol. Metab. 13 (2002) 35-43.
32. A.G. Mensah-Nyagan, J.L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, H. Vaudry, Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system, Pharmacol. Rev. 51 (1999) 63-81.
33. K. Tsutsui, Progesterone biosynthesis and action in the developing neuron, Endocrinology 149 (2008) 2757-2761.
34. M. Schumacher, S. Weill-Engerer, P. Liere, F. Robert, R.J. Franklin, L.M. Garcia- Segura, J.J. Lambert, W. Mayo, R.C. Melcangi, A. Parducz, U. Suter, C. Carelli, E. E. Baulieu, Y. Akwa, Steroid hormones and neurosteroids in normal and pathological aging of the nervous system, Prog. Neurobiol. 71 (2003) 3-29.
35. B. Stoffel-Wagner, Neurosteroid metabolism in the human brain, Eur. J. Endocrinol. 145 (2001) 669-679.
36. C. Le Goascogne, P. Robel, M. Gouezou, N. Sananes, E.E. Baulieu, M. Waterman, Neurosteroids: cytochrome P-450scc in rat brain, Science 237 (1987) 1212-1215.
37. S. Beyenburg, B. Stoffel-Wagner, M. Watzka, I. Blumcke, J. Bauer, J. Schramm, F. Bidlingmaier, C.E. Elger, Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy, Neuroreport 10 (1999) 3067-3070.
38. T. Inoue, J. Akahira, T. Suzuki, A.D. Darnel, C. Kaneko, K. Takahashi, M. Hatori, R. Shirane, T. Kumabe, Y. Kurokawa, S. Satomi, H. Sasano, Progesterone production and actions in the human central nervous system and neurogenic tumors, J. Clin. Endocrinol. Metab. 87 (2002) 5325-5331.
39. S.R. King, P.R. Manna, T. Ishii, P.J. Syapin, S.D. Ginsberg, K. Wilson, L.P. Walsh, K.L. Parker, D.M. Stocco, R.G. Smith, D.J. Lamb, An essential component in steroid synthesis the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain, J Neurosci 22 (2002) 10613-10620.
40. M. Watzka, F. Bidlingmaier, J. Schramm, D. Klingmuller, B. Stoffel-Wagner, Sex- and age-specific differences in human brain CYP11A1 mRNA expression, J. Neuroendocrinol. 11 (1999) 901-905.
41. L. Yu, D.G. Romero, C.E. Gomez-Sanchez, E.P. Gomez-Sanchez, Steroidogenic enzyme gene expression in the human brain, Mol. Cell Endocrinol. 190 (2002) 9-17.
42. S. Steckelbroeck, M. Watzka, R. Reichelt, V.H. Hans, B. Stoffel-Wagner, D.D. Heidrich, J. Schramm, F. Bidlingmaier, D. Klingmuller, Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain, J. Clin. Endocrinol. Metab. 86 (2001) 1324-1331.
43. N. Cherradi, E.M. Chambaz, G. Defaye, Organization of 3 beta-hydroxysteroid dehydrogenase/isomerase and cytochrome P450scc into a catalytically active molecular complex in bovine adrenocortical mitochondria, J. Steroid Biochem. Mol. Biol. 55 (1995) 507-514.
44. V. Luu The, Y. Lachance, C. Labrie, G. Leblanc, J.L. Thomas, R.C. Strickler, F. Labrie, Full length cDNA structure and deduced amino acid sequence of human 3 beta-hydroxy-5-ene steroid dehydrogenase, Mol. Endocrinol. 3 (1989) 1310-1312.
45. A. Midzak, M. Rone, Y. Aghazadeh, M. Culty, V. Papadopoulos, Mitochondrial protein import and the genesis of steroidogenic mitochondria, Mol. Cell Endocrinol. 336 (2011) 70-79.
46. C. Le Goascogne, M. Gouezou, P. Robel, G. Defaye, E. Chambaz, M.R. Waterman, E.E. Baulieu, The cholesterol side-chain cleavage complex in human brain white matter, J. Neuroendocrinol. 1 (1989) 153-156.
47. K. Ukena, M. Usui, C. Kohchi, K. Tsutsui, Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats, Endocrinology 139 (1998) 137-147.
48. K. Ukena, C. Kohchi, K. Tsutsui, Expression and activity of 3betahydroxysteroid dehydrogenase/delta5-delta4-isomerase in the rat Purkinje neuron during neonatal life, Endocrinology 140 (1999) 805-813.
49. H.J. Karavolas, D.R. Hodges, Neuroendocrine metabolism of progesterone and related progestins, Ciba Found. Symp. 153 (1990) 22-44 (Discussion 44-55).
50. D.L. Cheney, D. Uzunov, E. Costa, A. Guidotti, Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats, J. Neurosci. 15 (1995) 4641-4650.
51. C. Patte-Mensah, T.M. Penning, A.G. Mensah-Nyagan, Anatomical and cellular localization of neuroactive 5alpha/3alpha-reduced steroid-synthesizing enzymes in the spinal cord, J. Comp. Neurol. 477 (2004) 286-299.
52. R.C. Agis-Balboa, G. Pinna, A. Zhubi, E. Maloku, M. Veldic, E. Costa, A. Guidotti, Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14602-14607.
53. F. Labombarda, A. Pianos, P. Liere, B. Eychenne, S. Gonzalez, A. Cambourg, A.F. De Nicola, M. Schumacher, R. Guennoun, Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry, Endocrinology 147 (2006) 1847-1859.
54. D. Meffre, A. Pianos, P. Liere, B. Eychenne, A. Cambourg, M. Schumacher, D.G. Stein, R. Guennoun, Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry, Endocrinology 148 (2007) 2505-2517.
55. T.M. Penning, R.B. Sharp, N.R. Krieger, Purification and properties of 3 alphahydroxysteroid dehydrogenase from rat brain cytosol. Inhibition by nonsteroidal anti-inflammatory drugs and progestins, J. Biol. Chem. 260 (1985) 15266-15272.
56. D.W. Russell, J.D. Wilson, Steroid 5 alpha-reductase: two genes/two enzymes, Ann. Rev. Biochem. 63 (1994) 25-61.
57. H. Coirini, M. Gouezou, P. Liere, B. Delespierre, A. Pianos, B. Eychenne, M. Schumacher, R, Guennoun, 3 Beta-hydroxysteroid dehydrogenase expression in rat spinal cord, Neuroscience 113 (2002) 883-891.
58. P. Pozzi, C. Bendotti, S. Simeoni, F. Piccioni, V. Guerini, T.U. Marron, L. Martini, A. Poletti, Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones, J. Neuroendocrinol. 15 (2003) 882-887.
59. C. Patte-Mensah, V. Kappes, M.J. Freund-Mercier, K. Tsutsui, A.G. Mensah- Nyagan, Cellular distribution and bioactivity of the key steroidogenic enzyme cytochrome P450side chain cleavage, in sensory neural pathways, J. Neurochem. 86 (2003) 1233-1246.
60. J.L. Sanne, K.E. Krueger, Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization, J. Neurochem. 65 (1995) 528-536.
61. S.K. Mani, B.W. O'Malley, Mechanism of Progesterone Receptor Action in the Brain, in: D.W. Pfaff, P. Arnold, A.M. Etgen (Eds.), Molecular Mechanisms of Hormone Actions on Behavior, Academic Press, Amsterdam, 2009, pp. 375- 411.
62. M. Schumacher, R. Guennoun, Progesterone Synthesis, Metabolism, Mechanisms of Action, and Effects in the Nervous System. An Overview, in: D.W. Pfaff, A.P. Arnold, A.M. Etgen (Eds.), Molecular Mechanisms of Hormone Actions on Behavior, Academic Press, Amsterdam, 2009, pp. 413-452.
63. X. Li, J. Wong, S.Y. Tsai, M.J. Tsai, B.W. O'Malley, Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification, Mol. Cell. Biol. 23 (2003) 3763-3773.
64. R. Losel, M. Wehling, Nongenomic actions of steroid hormones, Nat. Rev. Mol. Cell Biol. 4 (2003) 46-56.
65. S.K. Mani, Signaling mechanisms in progesterone-neurotransmitter interactions, Neuroscience 138 (2006) 773-781.
66. P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, P. Chambon, Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B, EMBO J. 9 (1990) 1603-1614.
67. O.M. Conneely, J.P. Lydon, Progesterone receptors in reproduction: functional impact of the A and B isoforms, Steroids 65 (2000) 571-577.
68. G.S. Takimoto, L. Tung, H. Abdel-Hafiz, M.G. Abel, C.A. Sartorius, J.K. Richer, B. M. Jacobsen, D.L. Bain, K.B. Horwitz, Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure, J. Steroid Biochem. Mol. Biol. 85 (2003) 209-219.
69. S.E. Wardell, V. Boonyaratanakornkit, J.S. Adelman, A. Aronheim, D.P. Edwards, Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator, Mol. Cell Biol. 22 (2002) 5451-5466.
70. N.J. MacLusky, B.S. McEwen, Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others, Nature 274 (1978) 276-278.
71. N.J. MacLusky, B.S. McEwen, Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites, Endocrinology 106 (1980) 192-202.
72. B. Parsons, T.C. Rainbow, N.J. MacLusky, B.S. McEwen, Progestin receptor levels in rat hypothalamic and limbic nuclei, J. Neurosci. 2 (1982) 1446-1452.
73. I. Camacho-Arroyo, C. Guerra-Araiza, M.A. Cerbon, Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain, Neuroreport 9 (1998) 3993-3996.
74. C. Guerra-Araiza, A. Coyoy-Salgado, I. Camacho-Arroyo, Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain, Brain Res. Bull. 59 (2002) 105-109.
75. C. Guerra-Araiza, O. Villamar-Cruz, A. Gonzalez-Arenas, R. Chavira, I. Camacho-Arroyo, Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments, J. Neuroendocrinol. 15 (2003) 984-990.
76. C. Beyer, N. Damm, V. Brito, E. Kuppers, Developmental expression of progesterone receptor isoforms in the mouse midbrain, Neuroreport 13 (2002) 877-880.
77. C. Guerra-Araiza, A. Reyna-Neyra, A.M. Salazar, M.A. Cerbon, S. Morimoto, I. Camacho-Arroyo, Progesterone receptor isoforms expression in the prepuberal and adult male rat brain, Brain Res. Bull. 54 (2001) 13-17.
78. C. Bian, D. Zhang, Q. Guo, W. Cai, J. Zhang, Localization and sex-difference of steroid receptor coactivator-1 immunoreactivities in the brain of adult female and male mice, Steroids 76 (2011) 269-279.
79. O.C. Meijer, P.J. Steenbergen, E.R. De Kloet, Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary, Endocrinology 141 (2000) 2192-2199.
80. E. Nishihara, H. Yoshida-Komiya, C.S. Chan, L. Liao, R.L. Davis, B.W. O' Malley, J. Xu, SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells, J. Neurosci. 23 (2003) 213-222.
81. H. Ogawa, M. Nishi, M. Kawata, Localization of nuclear coactivators p300 and steroid receptor coactivator 1 in the rat hippocampus, Brain Res. 890 (2001) 197-202.
82. M.J. Tetel, N.K. Siegal, S.D. Murphy, Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors, J. Neuroendocrinol. 19 (2007) 262-271.
83. C.M. Tognoni, J.G. Chadwick, C.A. Ackeifi Jr., M.J. Tetel, Nuclear receptor coactivators are coexpressed with steroid receptors and regulated by estradiol in mouse brain, Neuroendocrinology 94 (2011) 49-57.
84. E. Nishihara, B.W. O 'Malley, J. Xu, Nuclear receptor coregulators are new players in nervous system development and function, Mol. Neurobiol. 30 (2004) 307-325.
85. M.J. Tetel, A.P. Auger, T.D. Charlier, Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior, Front Neuroendocrinol. 30 (2009) 328-342.
86. C. Neri, New light on polyglutamine neurodegenerative disorders: interference with transcription, Trends Mol. Med. 7 (2001) 283-284.
87. X.L. Tan, Y. Zhai, W.X. Gao, Y.M. Fan, F.Y. Liu, Q.Y. Huang, Y.Q. Gao, p300 expression is induced by oxygen deficiency and protects neuron cells from damage, Brain Res. 1254 (2009) 1-9.
88. M.K. Thakur, V. Paramanik, Role of steroid hormone coregulators in health and disease, Horm. Res. 71 (2009) 194-200.
89. F. Labombarda, R. Guennoun, S. Gonzalez, P. Roig, A. Lima, M. Schumacher, A. F. De Nicola, Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord, Neurosci. Lett. 288 (2000) 29-32.
90. F. Labombarda, S.L. Gonzalez, M.C. Deniselle, G.P. Vinson, M. Schumacher, A.F. De Nicola, R. Guennoun, Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord, J. Neurochem. 87 (2003) 902-913.
91. E.L. O'Bryant, Jordan, Expression of nuclear receptor coactivators in androgen-responsive and -unresponsive motoneurons, Horm. Behav. 47 (2005) 29-38.
92. R.N. Ranson, R.M. Santer, A.H. Watson, SRC-1 localisation in lumbosacral spinal cord of male and female Wistar rats, Neuroreport 14 (2003) 1821-1824.
93. C. Meyer, R. Schmid, P.C. Scriba, M. Wehling, Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes, Eur. J. Biochem. 239 (1996) 726-731.
94. O. Selmin, G.W. Lucier, G.C. Clark, A.M. Tritscher, J.P. Vanden Heuvel, J.A. Gastel, N.J. Walker, T.R. Sutter, D.A. Bell, Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, Carcinogenesis 17 (1996) 2609-2615.
95. C.J. Krebs, E.D. Jarvis, J. Chan, J.P. Lydon, S. Ogawa, D.W. Pfaff, A membraneassociated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors, Proc. Natl. Acad. Sci. U. S. A. (2000) 816-12821.
96. D. Meffre, B. Delespierre, M. Gouezou, P. Leclerc, G.P. Vinson, M. Schumacher, D.G. Stein, R. Guennoun, The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury, J. Neurochem. 93 (2005) 1314-1326.
97. R. Guennoun, D. Meffre, F. Labombarda, S.L. Gonzalez, M.C. Deniselle, D.G. Stein, A.F. De Nicola, M. Schumacher, The membrane-associated progester-one- binding protein 25-Dx: expression, cellular localization and upregulation after brain and spinal cord injuries, Brain Res. Rev. 57 (2008) 493-505.
98. J.J. Peluso, Multiplicity of progesterone's actions and receptors in the mammalian ovary, Biol. Reprod. 75 (2006) 2-8.
99. J. Xu, C. Zeng, W. Chu, F. Pan, J.M. Rothfuss, F. Zhang, Z. Tu, D. Zhou, D. Zeng, S. Vangveravong, F. Johnston, D. Spitzer, K.C. Chang, R.S. Hotchkiss, W.G. Hawkins, K.T. Wheeler, R.H. Mach, Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site, Nat. Commun. 2 (2011) 380.
100. P. Thomas, Y. Pang, J. Dong, Enhancement of cell surface expression and receptor functions of membrane progestin receptor alpha (mPRalpha) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors, Endocrinology 155 (2014) 1107-1119.
101. Y. Zhu, C.D. Rice, Y. Pang, M. Pace, P. Thomas, Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2231-2236.
102. Y. Zhu, J. Bond, P. Thomas, Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2237-2242.
103. Y. Pang, J. Dong, P. Thomas, Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors delta and {epsilon} (mPRdelta and mPR{epsilon}) and mPRdelta involvement in neurosteroid inhibition of apoptosis, Endocrinology 154 (2013) 283-295.
104. D. Meffre, F. Labombarda, B. Delespierre, A. Chastre, A.F. De Nicola, D.G. Stein, M. Schumacher, R. Guennoun, Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury, Neuroscience 231 (2013) 111-124.
105. P. Thomas, Y. Pang, Y. Zhu, C. Detweiler, K. Doughty, Multiple rapid progestin actions and progestin membrane receptor subtypes in fish, Steroids 69 (2004) 567-573.
106. B. Liu, L.A. Arbogast, Gene expression profiles of intracellular and membrane progesterone receptor isoforms in the mediobasal hypothalamus during prooestrus, J. Neuroendocrinol. 21 (2009) 993-1000.
107. N. Sleiter, Y. Pang, C. Park, T.H. Horton, J. Dong, P. Thomas, J.E. Levine, Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release, Endocrinology 150 (2009) 3833-3844.
108. K.A. Intlekofer, S.L. Petersen, Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain, Neuroscience 172 (2011) 55-65.
109. D.G. Zuloaga, S.L. Yahn, Y. Pang, A.M. Quihuis, M.G. Oyola, A. Reyna, P. Thomas, R.J. Handa, S.K. Mani, Distribution and estrogen regulation of membrane progesterone receptor-beta in the female rat brain, Endocrinology,153 4432-4443.
110. F. Labombarda, D. Meffre, B. Delespierre, S. Krivokapic-Blondiaux, A. Chastre, P. Thomas, Y. Pang, J.P. Lydon, S.L. Gonzalez, A.F. De Nicola, M. Schumacher, R. Guennoun, Membrane progesterone receptors localization in the mouse spinal cord, Neuroscience 166 (2010) 94-106.
111. A.M. Hosie, M.E. Wilkins, H.M. da Silva, T.G. Smart, Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites, Nature 444 (2006) 486-489.
112. D. Belelli, J.J. Lambert, Neurosteroids: endogenous regulators of the GABA(A) receptor, Nat. Rev. Neurosci. 6 (2005) 565-575.
113. M. Farrant, Z. Nusser, Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors, Nat. Rev. Neurosci. 6 (2005) 215-229.
114. A. Semyanov, M.C. Walker, D.M. Kullmann, R.A. Silver, Tonically active GABA A receptors: modulating gain and maintaining the tone, Trends Neurosci. 27 (2004) 262-269.
115. D. Belelli, N.L. Harrison, J. Maguire, R.L. Macdonald, M.C. Walker, D.W. Cope, Extrasynaptic GABAA receptors: form, pharmacology, and function, J. Neurosci. 29 (2009) 12757-12763.
116. M.J. Alldred, J. Mulder-Rosi, S.E. Lingenfelter, G. Chen, B. Luscher, Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin, J. Neurosci. 25 (2005) 594-603.
117. B. Luscher, T. Fuchs, C.L. Kilpatrick, GABAA receptor trafficking-mediated plasticity of inhibitory synapses, Neuron 70 (2011) 385-409.
118. B.M. Stell, S.G. Brickley, C.Y. Tang, M. Farrant, I. Mody, Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14439-14444.
119. R.M. Mihalek, P.K. Banerjee, E.R. Korpi, J.J. Quinlan, L.L. Firestone, Z.P. Mi, C. Lagenaur, V. Tretter, W. Sieghart, S.G. Anagnostaras, J.R. Sage, M.S. Fanselow, A. Guidotti, I. Spigelman, Z. Li, T.M. DeLorey, R.W. Olsen, G.E. Homanics, Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice, Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12905-12910.
120. D. Belelli, M.B. Herd, The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J. Neurosci. 23 (2003) 10013-10020.
121. P. Inquimbert, J.L. Rodeau, R. Schlichter, Regional differences in the decay kinetics of GABA(A) receptor-mediated miniature IPSCs in the dorsal horn of the rat spinal cord are determined by mitochondrial transport of cholesterol, J. Neurosci. 28 (2008) 3427-3437.
122. D. Chesnoy-Marchais, Progesterone and allopregnanolone enhance the miniature synaptic release of glycine in the rat hypoglossal nucleus, Eur. J. Neurosci. 30 (2009) 2100-2111.
123. D. Chesnoy-Marchais, Bicuculline- and neurosteroid-sensitive tonic chloride current in rat hypoglossal motoneurons and atypical dual effect of SR. 95,531, Eur. J. Neurosci. 37 (2013) 366-379.
124. S.J. Langmade, S.E. Gale, A. Frolov, I. Mohri, K. Suzuki, S.H. Mellon, S.U. Walkley, D.F. Covey, J.E. Schaffer, D.S. Ory, Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13807-13812.
125. J. Orans, D.G. Teotico, M.R. Redinbo, The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges, Mol. Endocrinol. 19 (2005) 2891-2900.
126. P. Thomas, Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions, Front Neuroendocrinol. 29 (2008) 292-312.
127. P. Thomas, Y. Pang, Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells, Neuroendocrinology 96 (2012) 162-171.
128. D. Caruso, A.M. Barron, M.A. Brown, F. Abbiati, P. Carrero, C.J. Pike, L.M. Garcia-Segura, R.C. Melcangi, Age-related changes in neuroactive steroid levels in 3xTg-AD mice, Neurobiol. Aging 34 (2013) 1080-1089.
129. P. Liere, Y. Akwa, S. Weill-Engerer, B. Eychenne, A. Pianos, P. Robel, J. Sjovall, M. Schumacher, E.E. Baulieu, Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography- mass spectrometry, J. Chromatogr. B Biomed. Sci. Appl. 739 (2000) 301-312.
130. P. Liere, A. Pianos, B. Eychenne, A. Cambourg, K. Bodin, W. Griffiths, M. Schumacher, E.E. Baulieu, J. Sjovall, Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key, J. Lipid Res. 50 (2009) 2430-2444.
131. R.L. Roof, R. Duvdevani, D.G. Stein, Gender influences outcome of brain injury: progesterone plays a protective role, Brain Res. 607 (1993) 333-336.
132. D.G. Stein, Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 24 (2001) 386-391.
133. R. Rupprecht, J.M. Reul, T. Trapp, B. van Steensel, C. Wetzel, K. Damm, W. Zieglgansberger, F. Holsboer, Progesterone receptor-mediated effects of neuroactive steroids, Neuron 11 (1993) 523-530.
134. C.L. Gibson, L.J. Gray, P.M. Bath, S.P. Murphy, Progesterone for the treatment of experimental brain injury; a systematic review, Brain 131 (2008) 318-328.
135. B. Wali, T. Ishrat, S. Won, D.G. Stein, I. Sayeed, Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study, Brain 137 (2014) 486-502.
136. S.L. Gonzalez, F. Labombarda, M.C. Gonzalez Deniselle, R. Guennoun, M. Schumacher, A.F. De Nicola, Progesterone up-regulates neuronal brainderived neurotrophic factor expression in the injured spinal cord, Neuroscience 125 (2004) 605-614.
137. F. Labombarda, S. Gonzalez, A. Lima, P. Roig, R. Guennoun, M. Schumacher, A. F. De Nicola, Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury, Exp. Neurol. 231 (2011) 135-146.
138. F. Labombarda, S.L. Gonzalez, A. Lima, P. Roig, R. Guennoun, M. Schumacher, A.F. de Nicola, Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury, Glia 57 (2009) 884-897.
139. D. Garcia-Ovejero, S. Gonzalez, B. Paniagua-Torija, A. Lima, E. Molina- Holgado, A.F. De Nicola, F. Labombarda, Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion, J. Neurotrauma 31 (2014) 857-871.
140. M. Meyer, M.C. Gonzalez Deniselle, L.I. Garay, G.G. Monachelli, A. Lima, P. Roig, R. Guennoun, M. Schumacher, A.F. De Nicola, Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration, Cellular and molecular neurobiology, 30 123-135.
141. M. Meyer, M.C. Gonzalez Deniselle, G. Gargiulo-Monachelli, L.I. Garay, M. Schumacher, R. Guennoun, A.F. De Nicola, Progesterone effects on neuronal brain-derived neurotrophic factor and glial cells during progression of Wobbler mouse neurodegeneration, Neuroscience 201 (2014) 267-279.
142. A.F. De Nicola, M.C. Gonzalez Deniselle, L. Garay, M. Meyer, G. Gargiulo- Monachelli, R. Guennoun, M. Schumacher, M.C. Carreras, J.J. Poderoso, Progesterone protective effects in neurodegeneration and neuroinflammation, J. Neuroendocrinol. 25 (2013) 1095-1103.
143. D.G. Stein, D.W. Wright, A.L. Kellermann, Does progesterone have neuroprotective properties? Ann. Emerg. Med. 51 (2008) 164-172.
144. Q. Guo, I. Sayeed, L.M. Baronne, S.W. Hoffman, R. Guennoun, D.G. Stein, Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats, Exp. Neurol. 198 (2006) 469-478.
145. R.L. Roof, R. Duvdevani, L. Braswell, D.G. Stein, Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats, Exp. Neurol. 129 (1994) 64-69.
146. K.J. Grossman, C.W. Goss, D.G. Stein, Effects of progesterone on the inflammatory response to brain injury in the rat, Brain Res. 1008 (2004) 29-39.
147. J. He, C.O. Evans, S.W. Hoffman, N.M. Oyesiku, D.G. Stein, Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury, Exp. Neurol. 189 (2004) 404-412.
148. C.L. Robertson, A. Puskar, G.E. Hoffman, A.Z. Murphy, M. Saraswati, G. Fiskum, Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats, Exp. Neurol. 197 (2006) 235-243.
149. I. Sayeed, S. Parvez, B. Wali, D. Siemen, D.G. Stein, Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone, Brain Res. 1263 (2009) 165-173.
150. J.W. VanLandingham, M. Cekic, S.M. Cutler, S.W. Hoffman, E.R. Washington, S. J. Johnson, D. Miller, D.G. Stein, Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury, J. Cereb. Blood Flow Metab. 28 (2008) 1786-1794.
151. Y. Zhang, Y. Xiong, A. Mahmood, Y. Meng, Z. Liu, C. Qu, M. Chopp, Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment, Brain Res. 1353 (2010) 249-257.
152. D.W. Wright, A.L. Kellermann, V.S. Hertzberg, P.L. Clark, M. Frankel, F.C. Goldstein, J.P. Salomone, L.L. Dent, O.A. Harris, D.S. Ander, D.W. Lowery, M.M. Patel, D.D. Denson, A.B. Gordon, M.M. Wald, S. Gupta, S.W. Hoffman, D.G. Stein, ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury, Ann. Emerg. Med. 49 (2007) 391-402 402 e391-392.
153. G. Xiao, J. Wei, W. Yan, W. Wang, Z. Lu, Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial, Crit. Care 12 (2008) R61.
154. N.J. Alkayed, S.J. Murphy, R.J. Traystman, P.D. Hurn, V.M. Miller, Neuroprotective effects of female gonadal steroids in reproductively senescent female rats, Stroke 31 (2000) 161-168.
155. C.L. Gibson, S.P. Murphy, Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice, J. Cereb. Blood Flow Metab. 24 (2004) 805-813.
156. N. Jiang, M. Chopp, D. Stein, H. Feit, Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats, Brain Res. 735 (1996) 101-107.
157. Y. Kumon, S.C. Kim, P. Tompkins, A. Stevens, S. Sakaki, C.M. Loftus, Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia, J. Neurosurg. 92 (2000) 848-852.
158. S.J. Murphy, M.T. Littleton-Kearney, P.D. Hurn, Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats, J. Cereb. Blood Flow Metab. 22 (2002) 1181-1188.
159. C.L. Gibson, D. Constantin, M.J. Prior, P.M. Bath, S.P. Murphy, Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia, Exp. Neurol. 193 (2005) 522-530.
160. I. Sayeed, B. Wali, D.G. Stein, Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion, Restor. Neurol. Neurosci. 25 (2007) 151-159.
161. T. Ishrat, I. Sayeed, F. Atif, D.G. Stein, Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats, Brain Res. 1257 (2009) 94-101.
162. J. Chen, M. Chopp, Y. Li, Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat, J. Neurol. Sci. 171 (1999) 24-30.
163. C.L. Gibson, B. Coomber, S.P. Murphy, Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice, Brain 134 (2011) 2125-2133.
164. S. Yousuf, I., Sayeed, F., Atif, H., Tang, J., Wang, D.G. Stein, Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats, Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 34 297-306.
165. T. Ishrat, I. Sayeed, F. Atif, F. Hua, D.G. Stein, Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases, Exp. Neurol. 226 (2010) 183-190.
166. J. Dang, B. Mitkari, M. Kipp, C. Beyer, Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats, Brain Behav. Immun. 25 (2011) 715-726.
167. C. Ulbrich, A. Zendedel, P. Habib, M. Kipp, C. Beyer, J. Dang, Long-term cerebral cortex protection and behavioral stabilization by gonadal steroid hormones after transient focal hypoxia, J. Steroid Biochem. Mol. Biol. 131 (2012) 10-16.
168. R. Wong, C. Renton, C.L. Gibson, S.J. Murphy, D.A. Kendall, P.M. Bath, Progesterone treatment for experimental stroke: an individual animal metaanalysis, J. Cereb. Blood Flow Metab. 33 (2013) 1362-1372.
169. C. Singh, L. Liu, J.M. Wang, R.W. Irwin, J. Yao, S. Chen, S. Henry, R.F. Thompson, R.D. Brinton, Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice, Neurobiol. Aging 33 (2012) 1493-1506.
170. J.M. Wang, P.B. Johnston, B.G. Ball, R.D. Brinton, The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression, J. Neurosci. 25 (2005) 4706-4718.
171. S. Chen, J.M. Wang, R.W. Irwin, J. Yao, L. Liu, R.D. Brinton, Allopregnanolone promotes regeneration and reduces beta-amyloid burden in a preclinical model of Alzheimer's disease, PloS One 6 (2011) e24293.
172. J.M. Wang, L. Liu, R.W. Irwin, S. Chen, R.D. Brinton, Regenerative potential of allopregnanolone, Brain Res. Rev. 57 (2008) 398-409.
173. F. Noorbakhsh, K.K. Ellestad, F. Maingat, K.G. Warren, M.H. Han, L. Steinman, G.B. Baker, C. Power, Impaired neurosteroid synthesis in multiple sclerosis, Brain 134 (2011) 2703-2721.
174. S.O. Adeosun, X. Hou, Y. Jiao, B. Zheng, S. Henry, R. Hill, Z. He, A. Pani, P. Kyle, X. Ou, T. Mosley, J.M. Farley, C. Stockmeier, I. Paul, S. Bigler, R.D. Brinton, R. Smeyne, J.M. Wang, Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease, PloS One 7 (2012) e50040.
175. P.M. Ismail, J. Li, F.J. DeMayo, B.W. O'Malley, J.P. Lydon, A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development, Mol. Endocrinol. 16 (2002) 2475-2489.
176. R. Sitruk-Ware, A. Nath, Metabolic effects of contraceptive steroids, Rev. Endocr. Metab. Disord. 12 (2011) 63-75.
177. F.Z. Stanczyk, J.P. Hapgood, S. Winer, D.R. Mishell Jr., Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects, Endocr. Rev. 34 (2013) 171-208.
178. N.V. Goletiani, D.R. Keith, S.J. Gorsky, Progesterone: review of safety for clinical studies, Exp. Clin. Psychopharmacol. 15 (2007) 427-444.
179. S.M. Cutler, E.H. Pettus, S.W. Hoffman, D.G. Stein, Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury, Exp. Neurol. 195 (2005) 423-429.
180. R.C. Melcangi, S. Giatti, M. Pesaresi, D. Calabrese, N. Mitro, D. Caruso, L.M. Garcia-Segura, Role of neuroactive steroids in the peripheral nervous system, Front Endocrinol. (Lausanne) 2 (2011) 104.
181. S.K. Bengtsson, M. Johansson, T. Backstrom, M. Wang, Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AbetaPP(Swe)PSEN1(DeltaE9) mice, J. Alzheimers Dis. 31 (2012) 71-84.
182. A. Rabinowitz, S.J. Cohen, D.A. Finn, R.W. Stackman, Jr., The neurosteroid allopregnanolone impairs object memory and contextual fear memory in male C57BL/6J mice, Horm. Behav. 66 (2014) 238-246.
183. I.M. Johansson, V. Birzniece, C. Lindblad, T. Olsson, T. Backstrom, Allopregnanolone inhibits learning in the Morris water maze, Brain Res. 934 (2002) 125-131.
184. D.B. Matthews, A.L. Morrow, S. Tokunaga, J.R. McDaniel, Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task Alcoholism, Clin. Exp. Res. 26 (2002) 1747-1751.
185. S. Turkmen, P. Lundgren, V. Birzniece, E. Zingmark, T. Backstrom, I.M. Johansson, 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone, Eur. J. Neurosci. 20 (2004) 1604-1612.
186. T. Backstrom, D. Haage, M. Lofgren, I.M. Johansson, J. Stromberg, S. Nyberg, L. Andreen, L. Ossewaarde, G.A. van Wingen, S. Turkmen, S.K. Bengtsson, Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons, Neuroscience 191 (2011) 46-54.
187. P. Thomas, Y. Pang, J. Dong, P. Groenen, J. Kelder, J. de Vlieg, Y. Zhu, C. Tubbs, Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins, Endocrinology 148 (2007) 705-718.
188. F.Z. Stanczyk, All progestins are not created equal, Steroids 68 (2003) 879-890.
189. J.P. Hapgood, D. Koubovec, A. Louw, D. Africander, Not all progestins are the same: implications for usage, Trends Pharmacol. Sci. 25 (2004) 554-557.
190. N.L. Moore, T.E. Hickey, L.M. Butler, W.D. Tilley, Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells, Mol. Cell Endocrinol. 357 (2010) 60-70.
191. M.T. Littleton-Kearney, J.A. Klaus, P.D. Hurn, Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat, J. Cereb. Blood Flow Metab. 25 (2005) 421-426.
192. J. Nilsen, R.D. Brinton, Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate, Endocrinology 143 (2002) 205-212.
193. J. Nilsen, R.D. Brinton, Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10506-10511.
194. K. Pazol, M.E. Wilson, K. Wallen, Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques, J. Clin. Endocrinol. Metab. 89 (2004) 2998-3006.
195. R. Hussain, M. El-Etr, O. Gaci, J. Rakotomamonjy, W.B. Macklin, N. Kumar, R. Sitruk-Ware, M. Schumacher, A.M. Ghoumari, Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors, Endocrinology 152 (2011) 3820-3831.
196. L. Liu, L. Zhao, H. She, S. Chen, J.M. Wang, C. Wong, K. McClure, R. Sitruk-Ware, R.D. Brinton, Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo, Endocrinology 151 (2010) 5782-5794.
197. B.G. Arnason, D.P. Richman, Effect of oral contraceptives on experimental demyelinating disease, Arch. Neurol. 21 (1969) 103-108.
198. M. Tomasicchio, C. Avenant, A. Du Toit, R.M.J.P. Ray Hapgood, The progestinonly contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor, PloS One 8 (2013) e62895.
199. P. Bouchard, Current and future medical treatments for menometrorrhagia during the premenopause, Gynecol. Endocrinol. 1 (2011) 1120-1125.
200. Y.S. Gwak, C.E. Hulsebosch, Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury, Curr. Pain Headache Rep. 15 (2011) 215-222.
201. M. Gasior, J.M. Witkin, S.R. Goldberg, P. Munzar, Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats, Eur. J. Pharmacol. 494 (2004) 183-189.
202. J.W. Marshall, A.R. Green, R.M. Ridley, Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures, Brain Res. 972 (2003) 119-126.
203. S.G. Sydserff, A.R. Borelli, A.R. Green, A.J. Cross, Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window, Br. J. Pharmacol. 135 (2002) 103-112.
204. J. Liu, L.N. Wang, Gamma aminobutyric acid (GABA) receptor agonists for acute stroke, Cochrane Database Syst. Rev. 2 (2013) CD009622. CD009622.